Health
Health Firms Odyssey, Mobia Fall After $454 Million IPO Haul
Odyssey Therapeutics Inc. signage during the company's IPO at the Nasdaq MarketSite in New York.
Photographer: Michael Nagle/BloombergA pair of healthcare companies ended their trading debuts lower after raising a combined $454 million in their initial public offerings.
Odyssey Therapeutics Inc. shares sank 8.8% after the biopharmaceutical company raised $304 million in an upsized US IPO and private placement.